Replies to post #4790 on Revive Therapeutics Ltd (RVVTF)

[powerbattles]

BINGO! Unlike remdesivir there is limited information known about the safety and effectiveness of using remdesivir to treat people in the hospital with COVID-19. Bucillamine, is a medication with a well-established safety. Bucillamine has shown significant potential to reduce lung inflammation damage associated with a serious infection.
IMHO:))) The U.S. Food and Drug Administration will issued an emergency use authorization for the compassionate use with "in a few week time".

“We are preparing plans for initiating the Phase 3 study upon the IND becoming active by the U.S. FDA and we look forward to advancing Bucillamine as a potential new treatment option for patients with a confirmed diagnosis of COVID-19 globally.”